DOI:
VOLUME - 7 ISSUE - 7 OCTOBER 2018
Dr. Joel Thomas*, Dr. Joshin Sara Cherian, Dr. Vijay M C
Department of Pharmacy Practice, Padmavathi College of Pharmacy and Research Institute, Periyanahalli, Dharampuri, Tamilnadu, India
ABSTRACT
Adverse drug reactions (ADRs) are an important clinical issue and a serious public health risk. ADRs leading to hospitalization or occurring during hospital stay contribute significantly to cancer patient morbidity and mortality as well as representing an additional cost for healthcare systems. Chemotherapy, a multimodal approach to oncological treatment, involves highly complex regimens and hence accounts to high susceptibility toward ADRs. In the present scenario the death rate due to cancer is gradually increasing. It is one of the leading causes of death in adult aged under 65 years. It was widely noted that 80-90% of the human cancer may be attributable to environmental and life style factors. Estimations reveal that in the year 2000 over 6 million people died due to cancer and ADR is considered to contribute to the fatality rate. So there is a need to create awareness among the physicians towards ADR monitoring in cancer patients .Our present study is to analyze the pattern of Adverse Drug Reaction occurring in cancer patients treated with anticancer agents and to suggest useful interventions to reduce the incidence of ADR. The aim of the present study is to assess the adverse drug reactions in male and female cancer patients in Government Head Quarters, Krishnagiri. This clinical relevant study strictly states that the intervention of a clinical pharmacist in treatment team, which can limit, predict, monitor, prevent and treat the occurrence of ADR on ANAs. The study was conducted in the North eastern part of Tamilnadu with less literacy rate and high rate of incidence in sexually transmitted disease.
Keywords:
Cancer, Clinical Pharmacist Interventional Management, Adverse Drug Reaction, Antineoplastic agent, Chemotherapy induced Side Effects.